Firefly Neuroscience (AIFF) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $12.4 million.
- Firefly Neuroscience's Liabilities and Shareholders Equity rose 13360.95% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year increase of 19486.97%. This contributed to the annual value of $4.6 million for FY2024, which is 7421.43% up from last year.
- Latest data reveals that Firefly Neuroscience reported Liabilities and Shareholders Equity of $12.4 million as of Q3 2025, which was up 13360.95% from $14.9 million recorded in Q2 2025.
- Firefly Neuroscience's Liabilities and Shareholders Equity's 5-year high stood at $23.4 million during Q4 2021, with a 5-year trough of $2.6 million in Q4 2023.
- Its 5-year average for Liabilities and Shareholders Equity is $9.9 million, with a median of $7.3 million in 2023.
- Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 51909.1% in 2021, then plummeted by 6901.81% in 2023.
- Quarter analysis of 5 years shows Firefly Neuroscience's Liabilities and Shareholders Equity stood at $23.4 million in 2021, then plummeted by 65.84% to $8.0 million in 2022, then tumbled by 66.91% to $2.6 million in 2023, then surged by 74.21% to $4.6 million in 2024, then skyrocketed by 169.66% to $12.4 million in 2025.
- Its last three reported values are $12.4 million in Q3 2025, $14.9 million for Q2 2025, and $12.4 million during Q1 2025.